Uric Acid-Lowering Medications: Options, Mechanisms & Monitoring

Hyperuricemia management combines urate-lowering therapy (ULT) with lifestyle. Target serum urate <6 mg/dL (<5 mg/dL if tophi).

Xanthine Oxidase Inhibitors (Reduce Production)

  • Allopurinol: First-line. Start 100 mg daily (50 mg if CKD), titrate monthly. Monitor for hypersensitivity (HLA-B*58:01 screen in high-risk populations).
  • Febuxostat: Alternative if allopurinol intolerant/contraindicated. CV risk warning (CARES trial); use with caution in CVD.

Uricosurics (Increase Renal Excretion)

  • Probenecid: Requires adequate renal function (CrCl >30 mL/min), good hydration, urine alkalinization. Contraindicated in urolithiasis.
  • Lesinurad: URAT1 inhibitor; only in combination with XOI (FDA). Renal monitoring required.

Adjuncts for Flare Prophylaxis (Not ULT)

  • Colchicine 0.6 mg daily/bid: Anti-inflammatory; start with ULT to prevent flares.
  • Low-dose NSAID/prednisone: Short-term if colchicine contraindicated.

Monitoring

  • Serum urate q1–3 months until target, then q6–12 months.
  • Renal function, LFTs, CBC periodically.
  • Flare management: continue ULT; treat flare separately.

Lifestyle

  • Limit purine-rich foods (organ meats, certain seafood, alcohol—especially beer).
  • Hydration ≥2 L/day.
  • Weight loss if overweight.
  • DASH/Mediterranean diet lowers urate modestly.

Urinary Disorders - Related Articles